141 related articles for article (PubMed ID: 24072042)
1. Tissue-specific differences in the regulation of KIBRA gene expression involve transcription factor TCF7L2 and a complex alternative promoter system.
Guske K; Schmitz B; Schelleckes M; Duning K; Kremerskothen J; Pavenstädt HJ; Brand SM; Brand E
J Mol Med (Berl); 2014 Feb; 92(2):185-96. PubMed ID: 24072042
[TBL] [Abstract][Full Text] [Related]
2. Promoter methylation inhibits expression of tumor suppressor KIBRA in human clear cell renal cell carcinoma.
Schelleckes K; Schmitz B; Ciarimboli G; Lenders M; Pavenstädt HJ; Herrmann E; Brand SM; Brand E
Clin Epigenetics; 2017; 9():109. PubMed ID: 29046731
[TBL] [Abstract][Full Text] [Related]
3. ZFP226 is a novel artificial transcription factor for selective activation of tumor suppressor KIBRA.
Schelleckes K; Schmitz B; Lenders M; Mewes M; Brand SM; Brand E
Sci Rep; 2018 Mar; 8(1):4230. PubMed ID: 29523820
[TBL] [Abstract][Full Text] [Related]
4. Elevated expression of Par3 promotes prostate cancer metastasis by forming a Par3/aPKC/KIBRA complex and inactivating the hippo pathway.
Zhou PJ; Xue W; Peng J; Wang Y; Wei L; Yang Z; Zhu HH; Fang YX; Gao WQ
J Exp Clin Cancer Res; 2017 Oct; 36(1):139. PubMed ID: 29017577
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation.
Lin KC; Moroishi T; Meng Z; Jeong HS; Plouffe SW; Sekido Y; Han J; Park HW; Guan KL
Nat Cell Biol; 2017 Jul; 19(8):996-1002. PubMed ID: 28752853
[TBL] [Abstract][Full Text] [Related]
6. Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling.
Ota M; Sasaki H
Development; 2008 Dec; 135(24):4059-69. PubMed ID: 19004856
[TBL] [Abstract][Full Text] [Related]
7. The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics.
Meliambro K; Wong JS; Ray J; Calizo RC; Towne S; Cole B; El Salem F; Gordon RE; Kaufman L; He JC; Azeloglu EU; Campbell KN
J Biol Chem; 2017 Dec; 292(51):21137-21148. PubMed ID: 28982981
[TBL] [Abstract][Full Text] [Related]
8. KIBRA exhibits MST-independent functional regulation of the Hippo signaling pathway in mammals.
Moleirinho S; Chang N; Sims AH; Tilston-Lünel AM; Angus L; Steele A; Boswell V; Barnett SC; Ormandy C; Faratian D; Gunn-Moore FJ; Reynolds PA
Oncogene; 2013 Apr; 32(14):1821-30. PubMed ID: 22614006
[TBL] [Abstract][Full Text] [Related]
9. Hippo Component TAZ Functions as a Co-repressor and Negatively Regulates ΔNp63 Transcription through TEA Domain (TEAD) Transcription Factor.
Valencia-Sama I; Zhao Y; Lai D; Janse van Rensburg HJ; Hao Y; Yang X
J Biol Chem; 2015 Jul; 290(27):16906-17. PubMed ID: 25995450
[TBL] [Abstract][Full Text] [Related]
10. KIBRA regulates Hippo signaling activity via interactions with large tumor suppressor kinases.
Xiao L; Chen Y; Ji M; Dong J
J Biol Chem; 2011 Mar; 286(10):7788-7796. PubMed ID: 21233212
[TBL] [Abstract][Full Text] [Related]
11. Genomic organization and regulation of the human orexin (hypocretin) receptor 2 gene: identification of alternative promoters.
Chen J; Randeva HS
Biochem J; 2010 Apr; 427(3):377-90. PubMed ID: 20156195
[TBL] [Abstract][Full Text] [Related]
12. Structural analysis of the cancer-specific promoter in mesothelin and in other genes overexpressed in cancers.
Ren YR; Patel K; Paun BC; Kern SE
J Biol Chem; 2011 Apr; 286(14):11960-9. PubMed ID: 21288909
[TBL] [Abstract][Full Text] [Related]
13. The transcriptional co-activator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members.
Mahoney WM; Hong JH; Yaffe MB; Farrance IK
Biochem J; 2005 May; 388(Pt 1):217-25. PubMed ID: 15628970
[TBL] [Abstract][Full Text] [Related]
14. KIBRA: In the brain and beyond.
Zhang L; Yang S; Wennmann DO; Chen Y; Kremerskothen J; Dong J
Cell Signal; 2014 Jul; 26(7):1392-9. PubMed ID: 24642126
[TBL] [Abstract][Full Text] [Related]
15. An alternative polyadenylation signal in TCF7L2 generates isoforms that inhibit T cell factor/lymphoid-enhancer factor (TCF/LEF)-dependent target genes.
Locke JM; Da Silva Xavier G; Rutter GA; Harries LW
Diabetologia; 2011 Dec; 54(12):3078-82. PubMed ID: 21913056
[TBL] [Abstract][Full Text] [Related]
16. The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1.
Janse van Rensburg HJ; Azad T; Ling M; Hao Y; Snetsinger B; Khanal P; Minassian LM; Graham CH; Rauh MJ; Yang X
Cancer Res; 2018 Mar; 78(6):1457-1470. PubMed ID: 29339539
[TBL] [Abstract][Full Text] [Related]
17. Integrative genomics analysis reveals the multilevel dysregulation and oncogenic characteristics of TEAD4 in gastric cancer.
Lim B; Park JL; Kim HJ; Park YK; Kim JH; Sohn HA; Noh SM; Song KS; Kim WH; Kim YS; Kim SY
Carcinogenesis; 2014 May; 35(5):1020-7. PubMed ID: 24325916
[TBL] [Abstract][Full Text] [Related]
18. The EZH2- H3K27me3-DNMT1 complex orchestrates epigenetic silencing of the wwc1 gene, a Hippo/YAP pathway upstream effector, in breast cancer epithelial cells.
Liu X; Li C; Zhang R; Xiao W; Niu X; Ye X; Li Z; Guo Y; Tan J; Li Y
Cell Signal; 2018 Nov; 51():243-256. PubMed ID: 30121333
[TBL] [Abstract][Full Text] [Related]
19. Dissection of the interaction between the intrinsically disordered YAP protein and the transcription factor TEAD.
Mesrouze Y; Bokhovchuk F; Meyerhofer M; Fontana P; Zimmermann C; Martin T; Delaunay C; Erdmann D; Schmelzle T; Chène P
Elife; 2017 Apr; 6():. PubMed ID: 28430104
[TBL] [Abstract][Full Text] [Related]
20. Dual promoter structure of ZFP106: regulation by myogenin and nuclear respiratory factor-1.
Grasberger H; Ye H; Mashima H; Bell GI
Gene; 2005 Jan; 344():143-59. PubMed ID: 15656981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]